Show
Sort by
-
- Journal Article
- A1
- open access
Serological response and breakthrough infection after COVID-19 vaccination in patients with cirrhosis and post-liver transplant
-
- Journal Article
- A1
- open access
R3-AFP score is a new composite tool to refine prediction of hepatocellular carcinoma recurrence after liver transplantation
-
Protective role of tacrolimus, deleterious role of age and comorbidities in liver transplant recipients with Covid-19 : results from the ELITA/ELTR multi-center European study
-
- Journal Article
- A1
- open access
International study on the outcome of locoregional therapy for liver transplant in hepatocellular carcinoma beyond Milan criteria
-
- Journal Article
- A1
- open access
Sirolimus use in liver transplant recipients with hepatocellular carcinoma: a randomized, multicenter, open-label phase 3 trial
-
- Journal Article
- A1
- open access
A prospective randomised, open-labeled, trial comparing sirolimus-containing versus mTOR-inhibitor-free immunosuppression in patients undergoing liver transplantation for hepatocellular carcinoma